Labs / CDMO: development & manufacturing
Entrada Therapeutics
Boston, MA, United States · entradatx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Entrada Therapeutics develops intracellular therapeutics using its EEV™ platform to address disease-causing targets inside cells. It focuses on programs for devastating diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, and serves patients through clinical-stage development from its corporate headquarters in Boston, Massachusetts.
They take quote requests by email.
What they offer
Intracellular therapeutics development
Develops therapeutics designed to reach and engage intracellular disease-causing targets.
EEV™ platform development
Uses its Endosomal Escape Vehicle platform to enable efficient intracellular delivery of therapeutics into organs and tissues.
Clinical studies
Advances treatments through clinical-stage programs.
Scientific publications
Publishes sponsored research and presentations with stated publication standards.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Oligonucleotide, Cell therapy
- Therapeutic areas
- rare diseases, neuromuscular disorders, Duchenne muscular dystrophy, myotonic dystrophy type 1, retinitis pigmentosa
- Sites
- Boston, USA
- Quality
- ICMJE Recommendations for the Conduct, R · ISMPP Good Publication Practice for Comm
- Address
- Spring 2027 Click here for additional information and program requireme
Similar labs. CDI Labs, Aurigene Pharmaceutical Services, Esco Aster, Porton
Found in a contract services directory. Listing built from entradatx.com. Work here? Claim this listing.